Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 651016

Known as: NSC-651016 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
HIV entry and fusion are two steps in the viral life cycle that can be targeted by several classes of antiviral drugs. The… Expand
Is this relevant?
Review
2005
Review
2005
Highly active antiretroviral therapy (HAART) dramatically changed the course of HIV infection. Currently, this therapy involves… Expand
Is this relevant?
Review
2004
Review
2004
Considerable advances have been made in the last years in the design of derivatives acting as inhibitors of HIV entry and fusion… Expand
Is this relevant?
2002
2002
CXCL12 (stromal cell-derived factor 1alpha), a ligand for CXCR4, has been shown to induce endothelial cell chemotaxis and to… Expand
Is this relevant?
2002
2002
CXCL12 (stromal cell-derived factor 1 ), a ligand for CXCR4, has been shown to induce endothelial cell chemotaxis and to… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
1998
Review
1998
The intersection of the HIV and the chemokine fields began with the observation that HIV entry into cells could be blocked by… Expand
Is this relevant?
1998
1998
Select chemokine receptors act as coreceptors for HIV-1 entry into human cells and represent targets for antiviral therapy. In… Expand
Is this relevant?